Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil
- 399 Downloads
To investigate the use of drugs, the extent and pattern of unlicensed and off-label use, and the potential relationship between off-label drug use and adverse drug reactions in northeastern Brazil.
A follow-up study of drug utilization in a general ward of a pediatric reference hospital, involving patients hospitalized for more than 24 h. Prescriptions and medical records were reviewed daily from August to December 2001. Drug licensing status of all prescriptions given to these patients was determined.
A total of 272 patients were admitted during the study, 265 (97.4%) of whom received one or more drugs. The median number of drugs/patient was 6 (1–18), and the most frequent diagnosis was pneumonia (29.4% of patients). The therapeutic class most prescribed was anti-infectives for systemic use (68.8% of all children). In all, 82.6% of children received at least one unlicensed or off-label drug, and 17% received both an unlicensed and an off-label drug. Dose/frequency was the most common form of off-label drug use. Off-label drug use was significantly associated with adverse drug reactions (relative risk 2.44; 95% CI 2.12, 2.89).
Although off-label drug use is a complex issue and is not synonymous with inappropriate drug use, a high rate of unlicensed/off-label drug use was found and was also associated with an increased risk of adverse drug reactions. More efforts are needed to increase rational drug use in children.
KeywordsPharmacoepidemiology Drug utilization Hospitalized children Off-label Unlicensed Pediatrics
- 3.Koren G, Macleod SM (1989) The state of pediatric clinical pharmacology: an international survey of training programs. Clin Pharmacol Ther 5:489–493Google Scholar
- 11.Gonzalez MG, Caroca CM, Paris E (1998) Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 36:530–533Google Scholar
- 16.Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J et al (2003) Identificação de medicamentos “não apropriados para crianças” em prescrições de unidades de tratamento intensivo pediátrica. J Pediatr 79:397–402Google Scholar
- 17.Desta Z, Abula T, Gebre-Yohannes A, Worku A (2002) Drug prescribing patterns for outpatients in three hospitals in north-west Ethiopia. Ethiop J Health Dev 16:183–189Google Scholar
- 22.Aseffa A, Yohannes G (1996) Antibiotic sensitivity patterns of prevalent bacterial pathogens in Gondar, Ethiopia. East Afr Med J 73:69–73Google Scholar
- 24.Leka T, Abadir M (1990) Prescribing pattern of analgesic drugs in 13 rural and regional hospitals of Ethiopia. Ethiop J Health Dev 4:15–30Google Scholar
- 31.Agência Nacional de Vigilância Sanitária, Ministério da Saúde, Brazil (2005) Bulário. http://bulario.bvs.br Accessed 2 July 2008
- 32.Martin J (2007) BNF for children. BMJ, LondonGoogle Scholar
- 33.Takemoto CK, Hodding JH, Kraus DM (2002) Pediatric dosage handbook. Lexi-Comp, Hudson, OHGoogle Scholar
- 34.World Health Organization (2007) WHO model list of essential medicines for children. First List, October 2007 http://www.who.int/childmedicines/publications/EMLc%20(2).pdf. Accessed 2 July 2008
- 40.Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, ‘t Jong G, de Hoog M, van den Anker JN (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J 320:79–82CrossRefGoogle Scholar